Effector Therapeutics (Series C)

Funding Details
Awarder
Inbox
Date Award
July 24, 2017
Vertical
Biopharmaceuticals
Funding URL
View Funding Page
Funding Amount:
$38,600,000

Company Info
Founders
Steve Worland
Company Description
Effector Therapeutics is an early-stage company focused on the discovery and development of small molecule cancer therapeutics.
Market
Cancer therapeutics
Location
San Diego, CA, USA
Coinvestors
AbbVie Biotech Ventures, Abingworth, Alexandria Real Estate Equities, Altitude Life Science Ventures, Astellas Venture Management, BioMed Ventures, Novartis Venture Funds, Pfizer Strategic Investments Group, Sectoral Asset Management, SR One, The Column Group, US Venture Partners

Links